Sinochips Diagnostics is helping communities and health systems safely navigate through this pandemic by leveraging our state-of-the-art CLIA lab to provide a rapid, accurate, and highly scalable solution to detect active COVID-19 infections

Sinochips Bioscience Gets FDA Emergency Use Authorization for Coronavirus Test

August 26, 2020
|
Sinochips Bioscience Gets FDA Emergency Use Authorization for Coronavirus Test

On 8/17/2020, Zhuhai Sinochips Bioscience Co., Ltd. received the FDA EUA for a multiplex SARS-CoV-2 diagnostic test kit. Sinochips Diagnostics performed part of the validation studies and prepared the submission.

Our laboratory is helping communities, schools, and health systems safely navigate through this pandemic by leveraging our state-of-the-art CLIA lab to provide a rapid, accurate, and highly scalable solution to detect active COVID-19 infections.

-Results available next day after sample receipt at Sinochips Diagnostics Laboratory for our diagnostic assay.
-Lab capability is 1,000+ samples per day and increasing.

We are recognized as a testing site by the State of Kansas, Department of Health and Environment.

For more information, please contact us at Support@Sinochipsdiagnostics.com